Skip to main content
SpringerLink
Log in

How Does Vonoprazan Affect the Treatment of Erosive Esophagitis?

  • Correspondence
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Cheng Y, Liu J, Tan X, et al. Direct comparison of the efficacy and safety of vonoprazan versus proton-pump inhibitors for gastroesophageal reflux disease: a systematic review and meta-analysis. Dig Dis Sci. 2020. https://doi.org/10.1007/s10620-020-06141-5.

    Article  PubMed  Google Scholar 

  2. Oshima T, Arai E, Taki M, et al. Randomised clinical trial: vonoprazan versus lansoprazole for the initial relief of heartburn in patients with erosive oesophagitis. Aliment Pharmacol Ther. 2019;49:140–146.

    Article  CAS  Google Scholar 

  3. Oshima T, Miwa H. Potent potassium-competitive acid blockers: a new era for the treatment of acid-related diseases. J Neurogastroenterol Motil. 2018;24:334–344.

    Article  Google Scholar 

  4. Scarpignato C, Hunt RH. Editorial: potassium-competitive acid blockers for acid-related diseases-tegoprazan, a new kid on the block. Aliment Pharmacol Ther. 2019;50:960–962.

    Article  Google Scholar 

  5. Sakurai K, Suda H, Fujie S, et al. Short-term symptomatic relief in gastroesophageal reflux disease: a comparative study of esomeprazole and vonoprazan. Dig Dis Sci. 2019;64:815–822. https://doi.org/10.1007/s10620-018-5365-0.

    Article  CAS  PubMed  Google Scholar 

  6. Ashida K, Sakurai Y, Hori T, et al. Randomised clinical trial: vonoprazan, a novel potassium-competitive acid blocker, versus lansoprazole for the healing of erosive oesophagitis. Aliment Pharmacol Ther. 2016;43:240–251.

    Article  CAS  Google Scholar 

  7. Ashida K, Iwakiri K, Hiramatsu N, et al. Maintenance for healed erosive esophagitis: phase III comparison of vonoprazan with lansoprazole. World J Gastroenterol. 2018;24:1550–1561.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology and Hepatology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan

    Tadayuki Oshima & Hiroto Miwa

Authors
  1. Tadayuki Oshima
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hiroto Miwa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tadayuki Oshima.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Oshima, T., Miwa, H. How Does Vonoprazan Affect the Treatment of Erosive Esophagitis?. Dig Dis Sci 66, 642–643 (2021). https://doi.org/10.1007/s10620-020-06387-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-020-06387-z

Search

Navigation